Periarticular multimodal drug cocktail injection for pain management

Periarticular multimodal drug cocktail injection for pain management after total hip arthroplasty supine: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1031180385

Enrollment

Registered

2019-03-20

Start date

2019-07-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coxarthrosis, avascular necrosis of femoral head

Interventions

A steroid, NSAIDs, local anesthetic are injected into the muscle and subcutaneous tissue during operation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with osteoarthritis of hip joint for total hip arthroplasty supine 2)Written informed consent

Exclusion criteria

Exclusion criteria: 1.Infection focus (or we are not limited to a hip joint after infection for less than 6 weeks) with the activity 2.Pyogenic arthritis 3.Osteomyelitis 4.The patient who has neurological disorder the instructions of the doctor are not obeyed. 5.Osteoporosis or Osteomalacia 6.Metabolic disorders with the ossiferous inhibition 7.A remote infection lesion with the possibility to spread in an implant 8.Rapidly destructive coxarthropathy 9.Vascular insufficiency, amyotrophy and neuromuscular disorders 10.The patient who has mental disorder the instructions of the doctor are not obeyed.

Design outcomes

Primary

Measure	Time frame
Postoperative pain	—

Secondary

Measure	Time frame
Adverse events	—

Contacts

Public ContactBaba Tomonori

Juntendo University Hospital

tobaba@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026